- Division of Translational and Clinical Sciences – DTCS
- Review Branch:
- Musculoskeletal, Skin, and Oral Sciences – MSOS
- Study Section:
- Musculoskeletal Tissue Engineering – MTE
Dr. Thomas Zeyda earned his Ph.D. from the Johannes Gutenberg University of Mainz Germany founded on loss-of-function studies that targeted the somatostatin system, which he performed as a guest researcher at the National Institute of Mental Health (NIMH). Throughout his academic path, at the Max-Planck Institute for Experimental Medicine (Göttingen, Germany), the University of Hawaii John A. Burns School of Medicine, and at Duke University, his research has focused on genetic modeling in a neuroscience context, which ultimately led him to a 10-year involvement at Ingenious Targeting Laboratory, Inc. There, he directed its small business funding efforts, providing custom genetically modified animals to external clients, and drove internal technology developments as Director of Technology Integration. Having rejoined the NIH again, Dr. Zeyda is looking forward to fostering the development of U.S. small businesses.